Oxygen Biotherapeutics is the tissue oxygenation company. We seek to help people maintain health,
enhance their skin's appearance and improve quality of life through clinical and topical oxygen delivery
via our proprietary Oxycyte perfluorocarbon emulsions, gels and lotions.
-
Funds breathe new life into Oxygen Biotherapeutics
By DAVID RANII
Posted on Wednesday, Jan. 25, 2012
After a tumultuous year that featured the dismissal of its CEO, drug-development company Oxygen Biotherapeutics is starting 2012 in its best financial shape in years.
The small, publicly traded Morrisville company turned a financial corner at the end of last year when it sold $7.5 million in preferred stock and warrants to institutional investors. The company received $3.5 million in December, with the second installment expected midyear.
In the past, Oxygen Bio has raised money that would carry it forward for about six months, but this was a richer deal. More...
Press Releases |
Become a Fan Facebook |
Follow us on Twitter |
